United Therapeutics (UTHR) Price to FCF (2009 - 2026)

United Therapeutics has disclosed Price to FCF across 18 years of filings, most recently posting 112.47 for Q2 2026.

• In Q2 2026, Price to FCF rose 12.1% year-over-year to 112.47; the TTM figure through Jun 2026 stood at 21.16 (up 74.39% YoY), while the FY2025 annual figure was 20.43, up 39.59% from the prior year.
• Price to FCF came in at 112.47 for Q2 2026 at United Therapeutics, up from 68.96 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 168.12 in Q2 2023 to a low of 29.52 in Q1 2022.
• Average Price to FCF over 5 years is 78.62, with a median of 65.56 recorded in 2026.
• Year-over-year, Price to FCF plunged 68.79% in 2022 and jumped 97.42% in 2025.
• Over 5 years, Price to FCF stood at 144.32 in 2022, then slipped by 0.45% to 143.66 in 2023, then slumped by 56.74% to 62.15 in 2024, then jumped by 97.42% to 122.71 in 2025, then decreased by 8.34% to 112.47 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 112.47 in Q2 2026, 68.96 in Q1 2026, and 122.71 in Q4 2025.